QR kȏd

Ceftriaxone therapy of serious bacterial infections in adults.

We evaluated the efficacy and safety of ceftriaxone in 50 adults with serious infections, usually giving 1 g every 12 h. Of the 35 patients who could be evaluated for clinical efficacy, 15 had failed on previous therapy, 15 had nosocomial infections, and all but 1 had underlying diseases. One patien...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Antimicrob Agents Chemother
Glavni autori: Bittner, M J, Dworzack, D L, Preheim, L C, Tofte, R W, Crossley, K B
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology (ASM) 1983
Teme:
Online pristup:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC186034/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6301365/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.23.2.261
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!